Revenue - Revenue from Customers as a Percentage of Total Product Revenue, Net (Details) - Gross product revenue - Customer	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
BioRidge Pharma, LLC
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	26.30%	0.00%
Cardinal
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	21.60%	23.10%
AmerisourceBergen Drug Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	20.90%	26.80%
McKesson Corporation
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	17.20%	21.60%